These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 22762059)
1. Association between complementary factor H Y402H polymorphisms and age-related macular degeneration in Chinese: Systematic review and meta-analysis. Quan YL; Zhou AY; Feng ZH Int J Ophthalmol; 2012; 5(2):242-6. PubMed ID: 22762059 [TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Thakkinstian A; Han P; McEvoy M; Smith W; Hoh J; Magnusson K; Zhang K; Attia J Hum Mol Genet; 2006 Sep; 15(18):2784-90. PubMed ID: 16905558 [TBL] [Abstract][Full Text] [Related]
3. Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis. Kondo N; Bessho H; Honda S; Negi A Ophthalmology; 2011 Feb; 118(2):339-44. PubMed ID: 20869121 [TBL] [Abstract][Full Text] [Related]
4. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis. Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Nazari R; Soheilian M Int Ophthalmol; 2019 Apr; 39(4):949-956. PubMed ID: 29423786 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration. Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788 [TBL] [Abstract][Full Text] [Related]
6. Association of Two Polymorphisms, rs1061170 and rs1410996, in Complement Factor H with Age-Related Macular Degeneration in an Asian Population: A Meta-Analysis. Wu M; Guo Y; Ma Y; Zheng Z; Wang Q; Zhou X Ophthalmic Res; 2016; 55(3):135-44. PubMed ID: 26727378 [TBL] [Abstract][Full Text] [Related]
7. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis. Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Soheilian M Acta Ophthalmol; 2018 Mar; 96(2):e105-e110. PubMed ID: 28593728 [TBL] [Abstract][Full Text] [Related]
8. Association between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis. Chen H; Yu KD; Xu GZ PLoS One; 2012; 7(8):e42464. PubMed ID: 22905135 [TBL] [Abstract][Full Text] [Related]
9. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis. Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M Int Ophthalmol; 2017 Dec; 37(6):1397-1409. PubMed ID: 28005184 [TBL] [Abstract][Full Text] [Related]
10. Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis. Hong N; Shen Y; Yu CY; Wang SQ; Tong JP Acta Ophthalmol; 2016 Jun; 94(4):334-45. PubMed ID: 27151934 [TBL] [Abstract][Full Text] [Related]
11. Association between complement factor H Val62Ile polymorphism and age-related macular degeneration susceptibility: a meta-analysis. Wang X; Geng P; Zhang Y; Zhang M Gene; 2014 Apr; 538(2):306-12. PubMed ID: 24440287 [TBL] [Abstract][Full Text] [Related]
12. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration. Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095 [TBL] [Abstract][Full Text] [Related]
13. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Goverdhan SV; Hannan S; Newsom RB; Luff AJ; Griffiths H; Lotery AJ Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302 [TBL] [Abstract][Full Text] [Related]
14. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663 [TBL] [Abstract][Full Text] [Related]
15. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials. Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS; JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032 [TBL] [Abstract][Full Text] [Related]
16. Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population. Soysal Y; Inan UÜ; Küsbeci T; Imirzalioğlu N DNA Cell Biol; 2012 Mar; 31(3):323-30. PubMed ID: 21790300 [TBL] [Abstract][Full Text] [Related]
17. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Schaumberg DA; Christen WG; Kozlowski P; Miller DT; Ridker PM; Zee RY Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2336-40. PubMed ID: 16723442 [TBL] [Abstract][Full Text] [Related]
18. Association of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis. Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M; Karimi S Curr Eye Res; 2016 Dec; 41(12):1519-1525. PubMed ID: 27269047 [TBL] [Abstract][Full Text] [Related]
19. Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions. Seitsonen S; Järvelä I; Meri S; Tommila P; Ranta P; Immonen I Acta Ophthalmol; 2008 Jun; 86(4):390-4. PubMed ID: 17995985 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis. Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y Sci Rep; 2015 Sep; 5():14517. PubMed ID: 26411831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]